These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11303216)

  • 1. Estrogens, progestins, selective estrogen receptor modulators, and the arterial tree.
    Wild RA; Reis SE
    Am J Obstet Gynecol; 2001 Apr; 184(5):1031-9. PubMed ID: 11303216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL
    Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of estrogens and progestins.
    LaRosa JC
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and the cardiovascular system: the critical role of progestins.
    Sitruk-Ware RL
    Climacteric; 2003 Oct; 6 Suppl 3():21-8. PubMed ID: 15018245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators and risk for coronary heart disease.
    Cano A; Hermenegildo C; Oviedo P; Tarín JJ
    Climacteric; 2007 Apr; 10(2):97-111. PubMed ID: 17453858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S; Liebson PR; Klein LW
    Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.